Skip to content

Effects of mucutin spray and Benzydamine Hydrochloride spray on prevention of radiation induced acute mucositis in head and neck cancer patients

Effects of mucutin spray and Benzydamine Hydrochloride spray on prevention of radiation induced acute mucositis in head and neck cancer patients: A comparative clinical study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20161024030467N1
Enrollment
44
Registered
2019-05-12
Start date
2019-09-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral mucositis. Oral mucositis (ulcerative)

Interventions

Intervention 1: Intervention group 1: Mucutin spray group who use the spray 4-8 times per day from a day before the start of radiotherapy up to two weeks of end of radiotherapy or until leaving the s

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Head and neck cancer and radiotherapy candidate age between 18 to 80 Life expectancy more than a year based on physician or team estimates Physical and mental ability to cooperate in filling in the questionnaire desire to participate in the study Good performance status with ECOG questionnaire At least 2 regions of the studied areas in terms of mucositis (based on the mucositis scale) be in the field of radiation therapy

Exclusion criteria

Exclusion criteria: Use of alcohol, drugs that affect salivary glands such as antipsychotics, opioids, antihypertensives, antihistanines, diuretics, mouthwashes and artificial saliva and cigarettes history of radiation therapy and chemotherapy in mouth or pharynx in recent six months history of connective tissue diseases such as Sogrene, rheumatoid arthritis, lupus; liver and kidney disease; major depression; diseases involving salivary glands such as diabetes; diseases causing dehydration such as chronic diarrhea, immune deficiency disorders, myelosuppression, diseases causing repeated oral aphthous Mucositis grade 3 and 4 Candidosis or oral herpes Pregnancy

Design outcomes

Primary

MeasureTime frame
Mucositis. Timepoint: At the baseline, Weeks 1,2,3,4,5,6,7. Method of measurement: Examination of oral cavity.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ghazaleh Heydarirad

Shahid Beheshti University of Medical Sciences

ghazalrad@yahoo.com+98 21 8877 6027

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 16, 2026